While we anticipated detecting genes previously implicated in colon cancer, the relative relationship to changes in CHRM1 expression suggests a common relationship between the concurrent changes observed in CHRM1 and APC/CTNNB1, and these downstream β-catenin target genes. The gene discussed is APC; the disease is colonic neoplasm.